相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Magnetic resonance molecular imaging of extradomain B fibronectin enables detection of pancreatic ductal adenocarcinoma metastasis
Peter L. Qiao et al.
MAGNETIC RESONANCE IMAGING (2022)
Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence
Beatrice Aramini et al.
CANCERS (2022)
Targeted Contrast Agents for Magnetic Resonance Molecular Imaging of Cancer
Zheng-Rong Lu et al.
ACCOUNTS OF CHEMICAL RESEARCH (2022)
Evaluation of Physicochemical Properties, Pharmacokinetics, Biodistribution, Toxicity, and Contrast-Enhanced Cancer MRI of a Cancer-Targeting Contrast Agent, MT218
Yajuan Li et al.
INVESTIGATIVE RADIOLOGY (2022)
Fibronectin in development and wound healing
Jennifer Patten et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Therapeutic Targeting of the Tumor Microenvironment
Leire Bejarano et al.
CANCER DISCOVERY (2021)
Efficacy of Targeted ECO/miR-200c Nanoparticles for Modulating Tumor Microenvironment and Treating Triple Negative Breast Cancer as Non-invasively Monitored by MR Molecular Imaging
Andrew L. Schilb et al.
PHARMACEUTICAL RESEARCH (2021)
Ensembl 2021
Kevin L. Howe et al.
NUCLEIC ACIDS RESEARCH (2021)
Human fibronectin extra domain B as a biomarker for targeted therapy in cancer
Relinde I. Y. Lieverse et al.
MOLECULAR ONCOLOGY (2020)
Visualizing and interpreting cancer genomics data via the Xena platform
Mary J. Goldman et al.
NATURE BIOTECHNOLOGY (2020)
Overexpression of Extradomain-B Fibronectin is Associated with Invasion of Breast Cancer Cells
Amita Vaidya et al.
CELLS (2020)
Preclinical Assessment of the Effectiveness of Magnetic Resonance Molecular Imaging of Extradomain-B Fibronectin for Detection and Characterization of Oral Cancer
Ryan C. Hall et al.
MOLECULAR IMAGING AND BIOLOGY (2020)
Early Diagnosis of Pancreatic Cancer: The Key for Survival
Gina Gheorghe et al.
DIAGNOSTICS (2020)
Magnetic Resonance Molecular Imaging of Extradomain B Fibronectin Improves Imaging of Pancreatic Cancer Tumor Xenografts
Peter Qiao et al.
FRONTIERS IN ONCOLOGY (2020)
Noninvasive assessment and therapeutic monitoring of drug-resistant colorectal cancer by MR molecular imaging of extradomain-B fibronectin
Amita Vaidya et al.
THERANOSTICS (2020)
Bi-specific tenascin-C and fibronectin targeted peptide for solid tumor delivery
Prakash Lingasamy et al.
BIOMATERIALS (2019)
Effective MR Molecular Imaging of Triple Negative Breast Cancer With an EDB-Fibronectin-Specific Contrast Agent at Reduced Doses
Nadia R. Ayat et al.
FRONTIERS IN ONCOLOGY (2019)
Magnetic resonance molecular imaging of metastatic breast cancer by targeting extradomain-B fibronectin in the tumor microenvironment
Zheng Han et al.
MAGNETIC RESONANCE IN MEDICINE (2018)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Optimization of ZD2 Peptide Targeted Gd(HP-DO3A) for Detection and Risk-Stratification of Prostate Cancer with MRI
Nadia R. Ayat et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
ED-B fibronectin expression is a marker of epithelial-mesenchymal transition in translational oncology
Iacopo Petrini et al.
ONCOTARGET (2017)
A drug-delivery strategy for overcoming drug resistance in breast cancer through targeting of oncofetal fibronectin
Phei Er Saw et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Toil enables reproducible, open source, big biomedical data analyses
John Vivian et al.
NATURE BIOTECHNOLOGY (2017)
Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer
Zheng Han et al.
NATURE COMMUNICATIONS (2017)
Fibronectin-guided migration of carcinoma collectives
Sandeep Gopal et al.
NATURE COMMUNICATIONS (2017)
Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRI
Zheng Han et al.
BIOCONJUGATE CHEMISTRY (2017)
Molecular imaging of the tumor microenvironment
Zhuxian Zhou et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Fibronectin-targeted drug delivery in cancer
Heena Kumra et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
EDB Fibronectin Specific Peptide for Prostate Cancer Targeting
Zheng Han et al.
BIOCONJUGATE CHEMISTRY (2015)
Differences in Breast Cancer Stage at Diagnosis and Cancer-Specific Survival by Race and Ethnicity in the United States
Javaid Iqbal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients
M. Pichler et al.
BRITISH JOURNAL OF CANCER (2014)
The extracellular matrix modulates the hallmarks of cancer
Michael W. Pickup et al.
EMBO REPORTS (2014)
Overexpression of fibronectin confers cell adhesion-mediated drug resistance ( CAM- DR) against 5-FU in oral squamous cell carcinoma cells
Yoshihiro Nakagawa et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Synthesis and therapeutic evaluation of an aptide-docetaxel conjugate targeting tumor-associated fibronectin
Hyungjun Kim et al.
JOURNAL OF CONTROLLED RELEASE (2014)
miR-200b and miR-200c as Prognostic Factors and Mediators of Gastric Cancer Cell Progression
Hailin Tang et al.
CLINICAL CANCER RESEARCH (2013)
Tumour heterogeneity and cancer cell plasticity
Corbin E. Meacham et al.
NATURE (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
The Genotype-Tissue Expression (GTEx) project
John Lonsdale et al.
NATURE GENETICS (2013)
Aptide-conjugated liposome targeting tumor-associated fibronectin for glioma therapy
Phei Er Saw et al.
JOURNAL OF MATERIALS CHEMISTRY B (2013)
Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
Martin Puhr et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Detection of cervical lymph node metastasis in head and neck cancer patients with clinically N0 neck-a meta-analysis comparing different imaging modalities
Li-Jen Liao et al.
BMC CANCER (2012)
Fibronectin extra domain B-specific aptide conjugated nanoparticles for targeted cancer imaging
Jinho Park et al.
JOURNAL OF CONTROLLED RELEASE (2012)
The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
Alexandra Naba et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
The tumor microenvironment controls drug sensitivity
Arne Ostman
NATURE MEDICINE (2012)
Tumor angiogenesis: molecular pathways and therapeutic targets
Sara M. Weis et al.
NATURE MEDICINE (2011)
Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process
Leonardo Freire-de-Lima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Targets of miR-200c mediate suppression of cell motility and anoikis resistance
Erin N. Howe et al.
BREAST CANCER RESEARCH (2011)
Three clinical-stage tumor targeting antibodies reveal differential expression of oncofetal fibronectin and tenascin-C isoforms in human lymphoma
Christoph Schliemann et al.
LEUKEMIA RESEARCH (2009)
New insights into form and function of fibronectin splice variants
E. S. White et al.
JOURNAL OF PATHOLOGY (2008)
The tumor microenvironment and its role in promoting tumor growth
T. L. Whiteside
ONCOGENE (2008)
Drug resistance and the solid tumor microenvironment
Olivier Tredan et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan
AF Muro et al.
JOURNAL OF CELL BIOLOGY (2003)
Squamous cell carcinomas of the head and neck
RJ Sanderson et al.
BMJ-BRITISH MEDICAL JOURNAL (2002)
Oncofetal fibronectin and oral squamous cell carcinoma
AJ Lyons et al.
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY (2001)
分享论文
